Virus hunters: using Nature's killers to fight CF lung infections
NCT ID NCT07275905
Summary
This early-stage study is testing whether a new treatment called AchromoPhage is safe for adults with cystic fibrosis who have long-term lung infections caused by Achromobacter bacteria. The treatment uses four naturally occurring viruses (called phages) that target and kill these specific bacteria. Researchers will enroll 12 participants to receive the treatment through inhalation, IV infusion, or both, monitoring for side effects and how the body responds over 42 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California San Diego (UCSD)
San Diego, California, 92037, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.